Personalized Medicine Global Market Report 2025

Description

Personalized medicine involves customizing medical treatment based on an individual's distinct genetic, environmental, and lifestyle factors, with the aim of preventing, diagnosing, and treating diseases in a more targeted manner. This approach strives to align the delivery of appropriate therapies with the specific needs of individual patients, ensuring that the right treatments are administered to the right individuals at the right time.

The primary products in personalized medicine comprise personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition and wellness. Personalized medicine diagnostics involves the study of an individual's specific genetic, molecular, and clinical characteristics to inform the diagnosis, treatment, and management of their disease. This approach is utilized in various applications such as disease diagnosis, treatment selection, monitoring treatment response, and clinical trial selection. Personalized medicine finds applications in diverse medical fields including oncology, neurology, blood transfusion safety, diabetes, autoimmune diseases, cardiology, and others. These products are employed in hospitals, diagnostic centers, research and academic institutes, and various healthcare settings.

The personalized medicine market research report is one of a series of new reports from The Business Research Company that provides personalized medicine market statistics, including personalized medicine industry global market size, regional shares, competitors with a personalized medicine market share, detailed personalized medicine market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine industry. This personalized medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized medicine market size has grown rapidly in recent years. It will grow from $386.27 billion in 2024 to $426.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases.

The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $662.67 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships.

The increasing prevalence of rare diseases is anticipated to drive the growth of the personalized medicine market. This rise pertains to the growing number of individuals diagnosed with conditions such as Klinefelter Syndrome, Aarskog Syndrome, and Abetalipoproteinemia. Personalized medicine provides tailored treatment options that cater to the specific needs of patients with rare diseases. For instance, in February 2024, the Genetic Alliance UK, a national charity based in the UK that supports individuals affected by genetic, rare, and undiagnosed conditions, reported that 3.5 million people in the UK are living with a rare condition, with 1 in 17 individuals likely to be affected by a rare condition at some point in their lives. Therefore, as the prevalence of rare diseases continues to rise, it is fueling the growth of the personalized medicine market.

The expanding population affected by obesity is anticipated to be a significant driver of the growth in the personalized medicine market in the future. Obesity, characterized by the abnormal or excessive accumulation of fat, poses health risks for individuals. Personalized medicine plays a crucial role in addressing the specific genetic and molecular factors contributing to obesity, enabling tailored and effective interventions. As of March 2022, the World Health Organization (WHO) reported that over 1 billion people worldwide are currently obese, with 650 million being adults, 340 million adolescents, and 39 million children. The WHO projects that by 2025, approximately 167 million adults and children will experience deteriorating health due to being overweight or obese. Consequently, the increasing prevalence of obesity stands as a key factor propelling the growth of the personalized medicine market.

Technological advancements have emerged as a prominent and widely embraced trend within the personalized medicine market. Major players in this sector are proactively integrating new technologies into their operations to fortify their market positioning. A notable example is OM1, a leading US-based healthcare company leveraging real-world data and artificial intelligence (AI) to support healthcare providers. In April 2023, OM1 secured a patent for its groundbreaking AI-powered platform designed to accelerate the field of personalized medicine. This cutting-edge technology harnesses the power of large-scale data analysis to extract meaningful insights pertaining to diagnoses, disease progression, and treatment responses. Its paramount significance lies in delivering customized healthcare inputs, thereby empowering informed decision-making for healthcare providers. Moreover, the platform expedites clinical trials by efficiently identifying suitable candidates, thereby contributing significantly to the progress of personalized medicine within the market.

Major players in the personalized medicine market are strategically concentrating on the introduction of innovative products, exemplified by the launch of real-world data programs geared towards enhancing precision medicine solutions in mental health. Real-world data programs involve the systematic collection and analysis of information derived from routine clinical practices and patient experiences, providing valuable insights to inform healthcare decisions and outcomes. A case in point is Tempus, a US-based technology company specializing in utilizing artificial intelligence for advancing precision medicine. In May 2022, Tempus unveiled Tempus N+, a psychiatric real-world data program that incorporates key features such as collaboration with academic medical institutions, an integrated operating system dedicated to mental health, secure data pipelines, and access to real-world data. Additionally, the program facilitates the expansion of psychiatric care through Electronic Medical Record (EMR) integration and pharmacogenomic testing.

In April 2023, 4D Molecular Therapeutics (4DMT), a clinical-stage gene therapy company based in the United States and dedicated to developing products for both rare and prevalent diseases, acquired the worldwide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc. for a sum of $140 million. This strategic acquisition marks a significant milestone in the field of personalized medicine, particularly in the treatment of rare and genetic diseases, with a specific focus on addressing geographic atrophy. By targeting the complement pathway, this acquisition has the potential to yield improvements in patient outcomes. Aevitas Therapeutics, Inc., also based in the United States, is a biopharmaceutical company specializing in the development and commercialization of gene therapies for complement-mediated diseases.

Major companies operating in the personalized medicine market include Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

North America was the largest region in the personalized medicine market in 2024. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized medicine market consists of sales of topical creams, serums, dietary supplements, customized meal plans, nutritional products, and drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Personalized Medicine Diagnostics; Personalized Medicine Therapeutics; Personalized Medical Care; Personalized Nutrition and Wellness
2) By Application: Oncology; Neurology; Blood Transfusion Safety; Diabetes; Autoimmune Diseases; Cardiology; Other Applications
3) By End-use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Other End-Users
Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing; Biomarker Testing; Companion Diagnostics; Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies; Gene Therapies; Monoclonal Antibodies; Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans; Patient-Centric Care Models; Digital Health Solutions; Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics; Customized Diet Plans; Supplement Personalization; Lifestyle Modification Programs
Companies Mentioned: Bayer AG; Novartis AG; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r26858

1. Executive Summary

2. Personalized Medicine Market Characteristics

3. Personalized Medicine Market Trends And Strategies

4. Personalized Medicine Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Personalized Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Personalized Medicine Market Growth Rate Analysis
5.4. Global Personalized Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Personalized Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Personalized Medicine Total Addressable Market (TAM)

6. Personalized Medicine Market Segmentation

6.1. Global Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Personalized Medicine Diagnostics
Personalized Medicine Therapeutics
Personalized Medical Care
Personalized Nutrition and Wellness
6.2. Global Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Blood Transfusion Safety
Diabetes
Autoimmune Diseases
Cardiology
Other Applications
6.3. Global Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Research and Academic Institutes
Other End-Users
6.4. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Medicine Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing
Biomarker Testing
Companion Diagnostics
Molecular Imaging
6.5. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Medicine Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Therapies
Gene Therapies
Monoclonal Antibodies
Cell and Gene Therapy Products
6.6. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Medical Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tailored Treatment Plans
Patient-Centric Care Models
Digital Health Solutions
Remote Patient Monitoring
6.7. Global Personalized Medicine Market, Sub-Segmentation Of Personalized Nutrition And Wellness, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nutrigenomics
Customized Diet Plans
Supplement Personalization
Lifestyle Modification Programs

7. Personalized Medicine Market Regional And Country Analysis

7.1. Global Personalized Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Personalized Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Medicine Market

8.1. Asia-Pacific Personalized Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Medicine Market

9.1. China Personalized Medicine Market Overview
9.2. China Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Medicine Market

10.1. India Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Medicine Market

11.1. Japan Personalized Medicine Market Overview
11.2. Japan Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Medicine Market

12.1. Australia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Medicine Market

13.1. Indonesia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Medicine Market

14.1. South Korea Personalized Medicine Market Overview
14.2. South Korea Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Medicine Market

15.1. Western Europe Personalized Medicine Market Overview
15.2. Western Europe Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Medicine Market

16.1. UK Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Medicine Market

17.1. Germany Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Medicine Market

18.1. France Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Medicine Market

19.1. Italy Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Medicine Market

20.1. Spain Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Medicine Market

21.1. Eastern Europe Personalized Medicine Market Overview
21.2. Eastern Europe Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Medicine Market

22.1. Russia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Medicine Market

23.1. North America Personalized Medicine Market Overview
23.2. North America Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Medicine Market

24.1. USA Personalized Medicine Market Overview
24.2. USA Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Medicine Market

25.1. Canada Personalized Medicine Market Overview
25.2. Canada Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Medicine Market

26.1. South America Personalized Medicine Market Overview
26.2. South America Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Medicine Market

27.1. Brazil Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Medicine Market

28.1. Middle East Personalized Medicine Market Overview
28.2. Middle East Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Medicine Market

29.1. Africa Personalized Medicine Market Overview
29.2. Africa Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Personalized Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Medicine Market Competitive Landscape And Company Profiles

30.1. Personalized Medicine Market Competitive Landscape
30.2. Personalized Medicine Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Medicine Market Other Major And Innovative Companies

31.1. Abbott Laboratories
31.2. Danaher Corporation
31.3. Eli Lilly and Company
31.4. Decode Genetics Inc.
31.5. GE HealthCare Technologies Inc.
31.6. Roche Diagnostics
31.7. Genentech Inc.
31.8. Biogen Inc.
31.9. Illumina Inc.
31.10. Qiagen N.V.
31.11. Exact Sciences Corporation
31.12. Myriad Genetics Inc.
31.13. Verily Life Sciences LLC
31.14. Guardant Health Inc.
31.15. Tempus Labs

32. Global Personalized Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Medicine Market

34. Recent Developments In The Personalized Medicine Market

35. Personalized Medicine Market High Potential Countries, Segments and Strategies

35.1 Personalized Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Personalized Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Personalized Medicine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer